Every SEC Form 3/4/5 on record for this filer (CIK 1491874) — 7 issuers, 108 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PRGO | PERRIGO Co plc | Director | 2016-11-14 → 2026-06-16 | 33 | $2M |
| ALLO | Allogene Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | 2023-10-16 → 2026-02-04 | 10 | −$95,400 |
| BTTX | Better Therapeutics, Inc. | Director · lapsed | 2021-11-01 → 2023-12-20 | 10 | $918,883 |
| CCXI | ChemoCentryx, Inc. | Director · lapsed | 2015-12-14 → 2022-10-24 | 21 | −$3M |
| TCDA | Tricida, Inc. | COO, CFO and EVP · lapsed | 2018-06-27 → 2022-03-02 | 18 | $4M |
| GHDX | GENOMIC HEALTH INC | Director · lapsed | 2016-06-23 → 2019-11-14 | 6 | — |
| SNSS | SUNESIS PHARMACEUTICALS INC | Director · lapsed | 2016-04-01 → 2017-06-02 | 8 | $58,276 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ALLO | 2026-02-02 | Sell | 24,001 | $1.76 | $42,242 | 1,252,795 |
| PRGO | 2025-11-12 | Buy | 7,500 | $14.18 | $106,350 | 17,375 |
| ALLO | 2025-10-21 | Sell | 36,744 | $1.26 | $46,297 | 1,276,796 |
| PRGO | 2025-08-18 | Buy | 4,375 | $22.97 | $100,494 | 33,287 |
| PRGO | 2025-08-18 | Buy | 4,375 | $22.97 | $100,494 | 9,875 |
2 of 7 issuers are covered and open a security page; the rest are on file here only.